Browse > Article
http://dx.doi.org/10.4014/jmb.1602.02022

A Synthetic Tul4 and FopA Peptide Cocktail of Francisella tularensis Induces Humoral and Cell-Mediated Immune Responses in Mice  

Oh, Hanseul (Department of Laboratory Animal Medicine, College of Veterinary Medicine, Seoul National University)
Kim, C-Yoon (Department of Laboratory Animal Medicine, College of Veterinary Medicine, Seoul National University)
Kim, Chang-Hwan (The 5th R&D Institute-3, Agency for Defense Development)
Hur, Gyeung-Haeng (The 5th R&D Institute-3, Agency for Defense Development)
Park, Jae-Hak (Department of Laboratory Animal Medicine, College of Veterinary Medicine, Seoul National University)
Publication Information
Journal of Microbiology and Biotechnology / v.26, no.9, 2016 , pp. 1613-1619 More about this Journal
Abstract
Francisella tularensis is a highly virulent pathogen of humans and other mammals. Moreover, F. tularensis has been designated a category A biothreat agent, and there is growing interest in the development of a protective vaccine. In the present study, we determine the in vitro and in vivo immune responses of a subunit vaccine composed of recombinant peptides Tul4 and FopA from epitopes of the F. tularensis outer membrane proteins. The recombinant peptides with adjuvant CpG induced robust immunophenotypic change of dendritic cell (DC) maturation and secretion of inflammatory cytokines (IL-6, IL-12). In addition, the matured DCs enabled ex vivo proliferation of naive splenocytes in a mixed lymphocyte reaction. Lastly, we determined the in vivo immune response by assessment of antibody production in C57BL/6 mice. Total IgG levels were produced after immunization and peaked in 6 weeks, and moreover, Tul4-specific IgG was confirmed in the mice receiving peptides with or without CpG. Based on these results, we concluded that the recombinant peptides Tul4 and FopA have immunogenicity and could be a safe subunit vaccine candidate approach against F. tularensis.
Keywords
Francisella tularensis; Tul4; FopA; subunit vaccine; immune response;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Ashtekar AR, Katz J, Xu Q, Michalek SM. 2012. A mucosal subunit vaccine protects against lethal respiratory infection with Francisella tularensis LVS. PLoS One 7: e50460.   DOI
2 Conlan JW. 2011. Tularemia vaccines: recent developments and remaining hurdles. Future Microbiol. 6: 391-405.   DOI
3 Cristillo AD, Wang S, Caskey MS, Unangst T, Hocker L, He L, et al. 2006. Preclinical evaluation of cellular immune responses elicited by a polyvalent DNA prime/protein boost HIV-1 vaccine. Virology 346: 151-168.   DOI
4 Dennis DT, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, et al. 2001. Tularemia as a biological weapon: medical and public health management. JAMA 285: 2763-2773.   DOI
5 Huntley JF, Conley PG, Rasko DA, Hagman KE, Apicella MA, Norgard MV. 2008. Native outer membrane proteins protect mice against pulmonary challenge with virulent type A Francisella tularensis. Infect. Immun. 76: 3664-3671.   DOI
6 Diehl S, Rincon M. 2002. The two faces of IL-6 on Th1/Th2 differentiation. Mol. Immunol. 39: 531-536.   DOI
7 Gregory SH, Mott S, Phung J, Lee J, Moise L, McMurry JA, et al. 2009. Epitope-based vaccination against pneumonic tularemia. Vaccine 27: 5299-5306.   DOI
8 Hickey AJ, Hazlett KR, Kirimanjeswara GS, Metzger DW. 2011. Identification of Francisella tularensis outer membrane protein A (FopA) as a protective antigen for tularemia. Vaccine 29: 6941-6947.
9 Jakob T, Walker PS, Krieg AM, Udey MC, Vogel JC. 1998. Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA. J. Immunol. 161: 3042-3049.
10 Kirimanjeswara GS, Olmos S, Bakshi CS, Metzger DW. 2008. Humoral and cell-mediated immunity to the intracellular pathogen Francisella tularensis. Immunol. Rev. 225: 244-255.   DOI
11 Kweon MN, Fujihashi K, VanCott JL, Higuchi K, Yamamoto M, McGhee JR, Kiyono H. 1998. Lack of orally induced systemic unresponsiveness in IFN-gamma knockout mice. J. Immunol. 160: 1687-1693.
12 Li W, Joshi M, Singhania S, Ramsey K, Murthy A. 2014. Peptide vaccine: progress and challenges. Vaccines 2: 515.   DOI
13 Macatonia SE, Hosken NA, Litton M, Vieira P, Hsieh CS, Culpepper JA, et al. 1995. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J. Immunol. 154: 5071-5079.
14 Roberts LM, Ledvina HE, Sempowski GD, Frelinger JA. 2014. TLR2 signaling is required for the innate, but not adaptive response to LVS clpB. Front. Immunol. 5: 426.
15 Morecki S, Gelfand Y, Yacovlev E, Eizik O, Shabat Y, Slavin S. 2008. CpG-induced myeloid CD11b+Gr-1+ cells efficiently suppress T cell-mediated immunoreactivity and graft-versus-host disease in a murine model of allogeneic cell therapy. Biol. Blood Marrow Transplant. 14: 973-984.   DOI
16 Valentino MD, Hensley LL, Skrombolas D, McPherson PL, Woolard MD, Kawula TH, et al. 2009. Identification of a dominant CD4 T cell epitope in the membrane lipoprotein Tul4 from Francisella tularensis LVS. Mol. Immunol. 46: 1830- 1838.   DOI
17 Napolitani G, Rinaldi A, Bertoni F, Sallusto F, Lanzavecchia A. 2005. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat. Immunol. 6: 769-776.   DOI
18 Park SJ, Nakagawa T, Kitamura H, Atsumi T, Kamon H, Sawa S, et al. 2004. IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation. J. Immunol. 173: 3844-3854.   DOI
19 Thakran S, Li H, Lavine CL, Miller MA, Bina JE, Bina XR, Re F. 2008. Identification of Francisella tularensis lipoproteins that stimulate the Toll-like receptor (TLR) 2/TLR1 heterodimer. J. Biol. Chem. 283: 3751-3760.   DOI
20 Wang BZ, Xu R, Quan FS, Kang SM, Wang L, Compans RW. 2010. Intranasal immunization with influenza VLPs incorporating membrane-anchored flagellin induces strong heterosubtypic protection. PLoS One 5: e13972.   DOI
21 Wingender G, Garbi N, Schumak B, Jungerkes F, Endl E, von Bubnoff D, et al. 2006. Systemic application of CpG-rich DNA suppresses adaptive T cell immunity via induction of IDO. Eur. J. Immunol. 36: 12-20.   DOI
22 Zhou W, Li Y, Pan X, Gao Y, Li B, Qiu Z, et al. 2013. Toll-like receptor 9 interaction with CpG ODN - an in silico analysis approach. Theor. Biol. Med. Model. 10: 18.   DOI